{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:37:47Z","timestamp":1763764667947,"version":"3.40.4"},"reference-count":26,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2016,3,15]]},"abstract":"<jats:p>Limited cutaneous scleroderma is a subtype of scleroderma limited to the skin of the face, hands, feet and forearms. We present a case of a 45-year-old woman affected by limited cutaneous systemic scleroderma involving the orofacial region and causing restricted mouth opening. The patient showed noteworthy improvement of the skin lesion by use of a combination of intralesional corticosteroid with hyaluronidase and various multiantioxidants, resulting in amelioration of her mouth opening problem. The patient gave her full informed written consent to this report being published.<\/jats:p>","DOI":"10.1136\/bcr-2015-212787","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T14:28:54Z","timestamp":1459434534000},"page":"bcr2015212787","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["A neoteric multidrug combination: novel approach to limited cutaneous systemic scleroderma involving the face"],"prefix":"10.1136","volume":"2016","author":[{"given":"M Hari","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M Siva","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabitha Hari","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kingsly Selva","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2016,3,31]]},"reference":[{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.1","first-page":"70","article-title":"Mandibular findings of systemic scleroderma: case report","volume":"11","author":"J\u00fanior","year":"2012","journal-title":"Int J Dent"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2006.07.004"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.3","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.113930"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2015.08.011"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.5","first-page":"831","article-title":"Small mouths\u2026Big problems? A review of scleroderma and its oral health implications","volume":"73","author":"Albilia","year":"2007","journal-title":"J Can Dent Assoc"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.6","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.tripleo.2010.04.004","article-title":"New alternative therapy for orofacial localized scleroderma","volume":"3","author":"Liu","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.7","doi-asserted-by":"publisher","DOI":"10.3345\/kjp.2015.58.9.354"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.5114\/pdia.2014.40971","article-title":"Acquired facial lipoatrophy: pathogenesis and therapeutic options","volume":"32","author":"Szczerkowska-Dobosz","year":"2015","journal-title":"Postepy Dermatol Alergol"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.9","doi-asserted-by":"publisher","DOI":"10.2174\/1874312901206010087"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.10","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-001-8063-1"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.11","doi-asserted-by":"publisher","DOI":"10.1586\/edm.11.26"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2010.04.001"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2013.01.018"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.14","doi-asserted-by":"publisher","DOI":"10.1080\/17402520500233437"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.15","doi-asserted-by":"publisher","DOI":"10.4103\/0973-029X.84481"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2015.08.002"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)01464-7"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.18","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2004.05805.x"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.19","doi-asserted-by":"publisher","DOI":"10.1159\/000360545"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2010.01585.x"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.21","doi-asserted-by":"crossref","first-page":"521958","DOI":"10.1155\/2012\/521958","article-title":"Modulation of fibrosis in systemic sclerosis by nitric oxide and antioxidants","volume":"2012","author":"Dooley","year":"2012","journal-title":"Cardiol Res Pract"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.22","doi-asserted-by":"crossref","first-page":"389582","DOI":"10.1155\/2014\/389582","article-title":"Oxidative damage and antioxidative therapy in systemic sclerosis","volume":"2014","author":"Grygiel-G\u00f3rniak","year":"2014","journal-title":"Mediators Inflamm"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.23","doi-asserted-by":"crossref","first-page":"705121","DOI":"10.1155\/2013\/705121","article-title":"Multiple molecular and cellular mechanisms of action of lycopene in cancer inhibition","volume":"2013","author":"Trejo-Sol\u00eds","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.24","first-page":"44","article-title":"Lycopene: structure, pharmacokinetics and role in oral cancer-precancerous lesions","volume":"1","author":"Mehta","year":"2012","journal-title":"J Res Adv Dent"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.25","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.70662"},{"key":"2025042703054761000_2016.mar31_3.bcr2015212787.26","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/ajcn\/85.5.1293","article-title":"Trace element supplementation after major burns modulates antioxidant status and clinical course by way of increased tissue trace element concentrations","volume":"85","author":"Berger","year":"2007","journal-title":"Am J Clin Nutr"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2015-212787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T10:05:53Z","timestamp":1745748353000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2015-212787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,31]]},"references-count":26,"alternative-id":["10.1136\/bcr-2015-212787"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2015-212787","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2016,3,31]]}}}